The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Lumican promotes calcific aortic valve disease through H3 histone lactylation
Abstract
BACKGROUND AND AIMS: Valve interstitial cells (VICs) undergo a transition to intermediate state cells before ultimately transforming into the osteogenic cell population, which is a pivotal cellular process in calcific aortic valve disease (CAVD). Herein, this study successfully delineated the stages of VIC osteogenic transformation and elucidated a novel key regulatory role of lumican (LUM) in this process. METHODS: Single-cell RNA-sequencing (scRNA-seq) from nine human aortic valves was used to characterize the pathological switch process and identify key regulatory factors. The in vitro, ex vivo, in vivo, and double knockout mice were constructed to further unravel the calcification-promoting effect of LUM. Moreover, the multi-omic approaches were employed to analyse the molecular mechanism of LUM in CAVD. RESULTS: ScRNA-seq successfully delineated the process of VIC pathological transformation and highlighted the significance of LUM as a novel molecule in this process. The pro-calcification role of LUM is confirmed on the in vitro, ex vivo, in vivo level, and ApoE-/-//LUM-/- double knockout mice. The LUM induces osteogenesis in VICs via activation of inflammatory pathways and augmentation of cellular glycolysis, resulting in the accumulation of lactate. Subsequent investigation has unveiled a novel LUM driving histone modification, lactylation, which plays a role in facilitating valve calcification. More importantly, this study has identified two specific sites of histone lactylation, namely, H3K14la and H3K9la, which have been found to facilitate the process of calcification. The confirmation of these modification sites' association with the expression of calcific genes Runx2 and BMP2 has been achieved through ChIP-PCR analysis. CONCLUSIONS: The study presents novel findings, being the first to establish the involvement of lumican in mediating H3 histone lactylation, thus facilitating the development of aortic valve calcification. Consequently, lumican would be a promising therapeutic target for intervention in the treatment of CAVD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Metabolic regulation of gene expression by histone lactylation
Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., Liu, W., Kim, S., Lee, S., Perez-Neut, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1678-1 · Cited by 4,371
Yu, J., Chai, P., Xie, M., Ge, S., Ruan, J., Fan, X., & Jia, R. (2021) · Genome Biology · doi:10.1186/s13059-021-02308-z · Cited by 940
Pan, R.-Y., He, L., Zhang, J., Liu, X., Liao, Y., Gao, J., Liao, Y., Yan, Y., Li, Q., Zhou, X., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.02.013 · Cited by 862
Histone Lactylation Boosts Reparative Gene Activation Post–Myocardial Infarction
Wang, N., Wang, W., Wang, X., Mang, G., Chen, J., Yan, X., Tong, Z., Yang, Q., Wang, M., Chen, L., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.320488 · Cited by 572
Aikawa, E., Nahrendorf, M., Sosnovik, D., Lok, V. M., Jaffer, F. A., Aikawa, M., & Weissleder, R. (2007) · Circulation · doi:10.1161/circulationaha.106.654913 · Cited by 418
Kottmann, R. M., Kulkarni, A. A., Smolnycki, K. A., Lyda, E., Dahanayake, T., Salibi, R., Honnons, S., Jones, C., Isern, N. G., Hu, J. Z., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0084oc · Cited by 415
Fan, M., Yang, K., Wang, X., Chen, L., Gill, P. S., Ha, T., Liu, L., Lewis, N. H., Williams, D. L., & Li, C. (2023) · Science Advances · doi:10.1126/sciadv.adc9465 · Cited by 403
Pan, L., Feng, F., Wu, J., Fan, S., Han, J., Wang, S., Yang, L., Liu, W., Wang, C., & Xu, K. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106270 · Cited by 383
Self-citationValve Interstitial Cells: The Key to Understanding the Pathophysiology of Heart Valve Calcification
Rutkovskiy, A., Malashicheva, A., Sullivan, G., Bogdanova, M., Kostareva, A., Stensløkken, K., Fiane, A., & Vaage, J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006339 · Cited by 358
Aortic Valve Stenosis: From Basic Mechanisms to Novel Therapeutic Targets
Goody, P. R., Hosen, M. R., Christmann, D., Niepmann, S. T., Zietzer, A., Adam, M., Bönner, F., Zimmer, S., Nickenig, G., & Jansen, F. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313067 · Cited by 331
Cited by
Feng, F., Wu, J., Chi, Q., Wang, S., Liu, W., Yang, L., Song, G., Pan, L., Xu, K., & Wang, C. (2024) · Advanced Science · doi:10.1002/advs.202405975 · Cited by 148
Self-citationWang, C., Liu, Z., Zhou, T., Wu, J., Feng, F., Wang, S., Chi, Q., Sha, Y., Zha, S., Shu, S., et al. (2025) · iMeta · doi:10.1002/imt2.70048 · Cited by 83
Self-citationLactylation in health and disease: physiological or pathological?
Zhao, L., Qi, H., Lv, H., Liu, W., Zhang, R., & Yang, A. (2025) · Theranostics · doi:10.7150/thno.105353 · Cited by 83
NLRP3 inflammasome in cardiovascular diseases: an update
Mo, B., Ding, Y., & Ji, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550226 · Cited by 78
Calcific aortic stenosis: omics-based target discovery and therapy development
Blaser, M. C., Bäck, M., Lüscher, T. F., & Aikawa, E. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehae829 · Cited by 45
“24,69,86,129 114 Single-cell techniques may also enable differentiation of BAV vs. TAV-associated disease-driving mechanisms, while cusp-specific studies could shed light on how shear-stress or flow-related modulate cellular subpopulations in the valve.”
Metadata
- Authors
- Huang, Y., Wang, C., Zhou, T., Xie, F., Liu, Z., Xu, H., Liu, M., Wang, S., Li, L., Chi, Q., Shi, J., Dong, N., & Xu, K.
- Affiliations
- Wuhan Union Hospital (CN)
- Hubei University of Chinese Medicine (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Wuhan University of Technology (CN)
- Corresponding author
- Wang, Chunli
- Shi, Jiawei
- Dong, Nianguo
- Xu, Kang
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-07-08
- Volume
- 45
- Issue
- 37
- Pages
- 3871-3885
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W4400414483
- Semantic Scholar
- f40e7d6b45449d8c43ec31bf12b46f7d9fb63fbf
- Cited by
- 124
- References
- 61
- Citations by year
- 2026: 35 · 2025: 58 · 2024: 31
- FWCI
- 37.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82204659, 82300413, 82200410, 82370379, 82300416)
- Jiangsu Provincial Basic Research Program Natural Science Foundation Youth Fund Project (BK20230732)
- Young Talent Elite Scientists Sponsorship Program of China Association of Chinese Medicine (CACM-2023-QNRC2-B06)
- China Postdoctoral Science Foundation (2022M721263)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- lumican, calcific aortic valve disease, valvular interstitial cells, histone lactylation, histone modifications, Runx2, BMP-2, lactate accumulation, inflammation, aortic valve calcification, therapeutic target
- MeSH terms
- Lumican, Animals, Aortic Valve, Aortic Valve Stenosis, Calcinosis, Histones, Humans, Male, Osteogenesis, Mice, Knockout, Core Binding Factor Alpha 1 Subunit, Mice, Bone Morphogenetic Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lumican promotes calcific aortic valve disease through H3 histone lactylation. https://app.cochat.ai/papers/10.1093/eurheartj/ehae407
- The paper
- Huang, Y., Wang, C., Zhou, T., Xie, F., Liu, Z., Xu, H., Liu, M., Wang, S., Li, L., Chi, Q., Shi, J., Dong, N., & Xu, K. (2024). Lumican promotes calcific aortic valve disease through H3 histone lactylation. European Heart Journal. https://doi.org/10.1093/eurheartj/ehae407
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.